Donna Roy Grogan

Companies

• C4 Therapeutics (United States)Board member Aug 2, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• C4 Therapeutics (United States) CCCC74,853 shares²$216.0K at $2.88Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Granted 3,341 shares at $4.34 of C4 Therapeutics (United States)²
• Apr 1, 2026Granted 5,370 shares at $2.70 of C4 Therapeutics (United States)³
• Jan 2, 2026Granted 7,513 shares at $1.93 of C4 Therapeutics (United States)⁴
• Oct 1, 2025Granted 6,740 shares at $2.15 of C4 Therapeutics (United States)⁵
• Jul 1, 2025Granted 9,609 shares at $1.51 of C4 Therapeutics (United States)⁶
• Apr 1, 2025Granted 9,581 shares at $1.44 of C4 Therapeutics (United States)⁷
• Jan 2, 2025Granted 3,757 shares at $3.66 of C4 Therapeutics (United States)⁸
• Oct 1, 2024Granted 2,474 shares at $5.56 of C4 Therapeutics (United States)⁹
• Jul 1, 2024Granted 2,836 shares at $4.85 of C4 Therapeutics (United States)¹⁰
• Apr 1, 2024Granted 1,697 shares at $8.10 of C4 Therapeutics (United States)¹¹
• Jan 2, 2024Granted 2,108 shares at $6.52 of C4 Therapeutics (United States)¹²
• Oct 2, 2023Granted 8,089 shares at $1.70 of C4 Therapeutics (United States)¹³
• Jul 3, 2023Granted 4,858 shares at $2.83 of C4 Therapeutics (United States)¹⁴
• Apr 3, 2023Granted 4,298 shares at $3.20 of C4 Therapeutics (United States)¹⁵
• Jan 3, 2023Granted 1,763 shares at $6.38 of C4 Therapeutics (United States)¹⁶
• Oct 3, 2022Granted 819 shares at $8.69 of C4 Therapeutics (United States)¹⁷